Structure and function of nucleotide sugar transporters: Current progress

Computational and Structural Biotechnology Journal

Volumn 10, Issue 16, 2014, Pages 23-32

  Hadley, Barbara ^a   Maggioni, Andrea ^a   Ashikov, Angel ^b,c   Day, Christopher J ^a   Haselhorst, Thomas ^a   Tiralongo, Joe ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

CMP sialic acid transporter; Endoplasmic reticulum; Golgi apparatus; Nucleotide sugar transporters; STD NMR spectroscopy

Indexed keywords

GUANOSINE DIPHOSPHATE FUCOSE; MEMBRANE PROTEIN; N ACETYLGLUCOSAMINE; NUCLEOTIDE TRANSPORTER; PROTEOME; URIDINE DIPHOSPHATE; URIDINE DIPHOSPHATE GALACTOSE;

ARCHAEON; BACTERIUM; CYTOSOL; ENDOPLASMIC RETICULUM; EUKARYOTE; GOLGI COMPLEX; NONHUMAN; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; REVIEW; STRUCTURE ACTIVITY RELATION; SUGAR TRANSPORT;

EUKARYOTA;

EID: 84907414376     PISSN: None     EISSN: 20010370     Source Type: Journal    
DOI: 10.1016/j.csbj.2014.05.003     Document Type: Review

References (103)

1. Shental-Bechor D, Levy Y. Effect of glycosylation on protein folding: a close look at thermodynamic stabilization. Proc Natl Acad Sci U S A 2008; 105:8256-61.
2. Hayashi H, Yamashita Y. Role of N-glycosylation in cell surface expression and protection against proteolysis of the intestinal anion exchanger SLC26A3. Am J Physiol Cell Physiol 2012; 302:C781-95.
3. van Kooyk Y, Rabinovich GA. Protein-glycan interactions in the control of innate and adaptive immune responses. Nat Immunol 2008; 9:593-601.
4. Zhao YY, Takahashi M, Gu J.G., Miyoshi E., Matsumoto A, Kitazume S, et al. Functional roles of N-glycans in cell signaling and cell adhesion in cancer. Cancer Sci 2008; 99:1304-10.
5. Zhou F, Xu W, Hong M., Pan Z, Sinko PJ, Ma J, et al. The role of N-linked glycosylation in protein folding, membrane targeting, and substrate binding of human organic anion transporter hOAT4. Mol Pharmacol 2005; 67:868-76.
6. Fredriksson R, Nordstrom KJ, Stephansson O, Hagglund M.G., Schioth HB. The solute carrier (SLC) complement of the human genome: phylogenetic classification reveals four major families. FEBS Lett 2008; 582:3811-6.
7. Hediger MA, Romero MF, Peng J.B., Rolfs A., Takanaga H, Bruford EA. The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteinsIntroduction. Pflugers Arch 2004; 447:465-8.
8. Caffaro CE, Hirschberg CB. Nucleotide sugar transporters of the Golgi apparatus: from basic science to diseases. Acc Chem Res 2006; 39:805-12.
9. Abeijon C, Mandon EC, Hirschberg CB. Transporters of nucleotide sugars, nucleotide sulfate and ATP in the Golgi apparatus. Trends Biochem Sci 1997; 22:203-7.
10. Capasso JM, Hirschberg CB. Mechanisms of glycosylation and sulfation in the Golgi apparatus: evidence for nucleotide sugar/nucleoside monophosphate and nucleotide sulfate/nucleoside monophosphate antiports in the Golgi apparatus membrane. Proc Natl Acad Sci U S A 1984; 81:7051-5.
11. Milla ME, Clairmont CA, Hirschberg CB. Reconstitution into proteoliposomes and partial purification of the Golgi apparatus membrane UDP-galactose, UDP-xylose, and UDP-glucuronic acid transport activities. J Biol Chem 1992; 267:103-7.
12. Tiralongo J, Ashikov A, Routier F., Eckhardt M, Bakker H, Gerardy-Schahn R, et al. Functional expression of the CMP-sialic acid transporter in Escherichia coli and its identification as a simple mobile carrier. Glycobiology 2006; 16:73-81.
13. Berninsone P, Eckhardt M, Gerardy-Schahn R, Hirschberg CB. Functional expression of the murine Golgi CMP-sialic acid transporter in Saccharomyces cerevisiae. J Biol Chem 1997; 272:12616-9.
14. Maggioni A, Martinez-Duncker I, Tiralongo J. CMP-sialic acid transporter. In: Tiralongo J, Martinez-Duncker I, editors. Sialobiology: structure, biosynthesis and function sialic acid glycoconjugates in health and disease Sharjah. United Arab Emirates: Bentham Science Publishers; 2013. p. 115-38.
15. Martinez-Duncker I, Dupre T, Piller V., Piller F, Candelier JJ, Trichet C, et al. Genetic complementation reveals a novel human congenital disorder of glycosylation of type II, due to inactivation of the Golgi CMP-sialic acid transporter. Blood 2005; 105:2671-6.
16. Mohamed M, Ashikov A, Guillard M., Robben JH, Schmidt S, van den Heuvel B, et al. Intellectual disability and bleeding diathesis due to deficient CMP-sialic acid transport. Neurology 2013; 81:681-7.
17. Kumamoto K, Goto Y, Sekikawa K., Takenoshita S, Ishida N, Kawakita M., et al. Increased expression of UDP-galactose transporter messenger RNA in human colon cancer tissues and its implication in synthesis of Thomsen-Friedenreich antigen and sialyl Lewis A/X determinants. Cancer Res 2001; 61:4620-7.
18. Hara T, Yamauchi M, Takahashi E., Hoshino M, Aoki K, Ayusawa D., et al. The UDP-galactose translocator gene is mapped to band Xp11.23-p11.22 containing the Wiskott-Aldrich syndrome locus. Somat Cell Mol Genet 1993; 19:571-5.
19. Kodera H, Nakamura K, Osaka H., Maegaki Y, Haginoya K, Mizumoto S., et al. De novo mutations in SLC35A2 encoding a UDP-galactose transporter cause early-onset epileptic encephalopathy. Hum Mutat 2013; 34:1708-14.
20. Ng BG, Buckingham KJ, Raymond K, Kircher M., Turner EH, HeM, et al. Mosaicism of the UDP-galactose transporter SLC35A2 causes a congenital disorder of glycosylation. Am J Hum Genet 2013; 92:632-6.
21. Tran CV, Saier Jr MH. The principal chloroquine resistance protein of Plasmodium falciparum is a member of the drug/metabolite transporter superfamily. Microbiology 2004; 150:1-3.
22. Thomsen B, Horn P, Panitz F., Bendixen E, Petersen AH, Holm L.E., et al. A missense mutationinthe bovine SLC35A3 gene, encoding a UDP-N-acetylglucosamine transporter, causes complex vertebral malformation. Genome Res 2006; 16:97-105.
23. Edvardson S, Ashikov A, Jalas C., Sturiale L, Shaag A, Fedick A., et al. Mutations in SLC35A3 cause autism spectrum disorder, epilepsy and arthrogryposis. J Med Genet 2013; 50:733-9.
24. Kamiyama S, Ichimiya T, Ikehara Y., Takase T, Fujimoto I, Suda T., et al. Expression and the role of 3'-phosphoadenosine 5'-phosphosulfate transporters in human colorectal carcinoma. Glycobiology 2011; 21:235-46.
25. Faiyaz ul Haque M, King LM, Krakow D, Cantor RM, Rusiniak ME, Swank RT, et al. Mutations in orthologous genes in human spondyloepimetaphyseal dysplasia and the brachymorphic mouse. Nat Genet 1998; 20:157-62.
26. Li D, Song YM, Zhan QM. Specifically up-regulated non-coding RNA gene HULC in tumor cell lines and its effects on the expression of neighboring gene SLC35B3. Zhonghua Yi Xue Za Zhi 2010; 90:3156-9.
27. Kamiyama S, Sasaki N, Goda E., Ui-Tei K, Saigo K, Narimatsu H., et al. Molecular cloning and characterization of a novel 3'-phosphoadenosine 5'-phosphosulfate transporter, PAPST2. J Biol Chem 2006; 281:10945-53.
28. Yazbek SN, Buchner DA, Geisinger J.M., Burrage LC, Spiezio SH, Zentner GE, et al. Deep congenic analysis identifies many strong, context-dependent QTLs, one of which, Slc35b4, regulates obesity and glucose homeostasis. Genome Res 2011; 21:1065-73.
29. Siegel DH, Shieh JT, Kwon E.K., Baselga E., Blei F, Cordisco M, et al. Copy number variation analysis in 98 individuals with PHACE syndrome. J Invest Dermatol 2013; 133:677-84.
30. Luhn K, Wild MK, Eckhardt M, Gerardy-Schahn R, Vestweber D. The gene defective in leukocyte adhesion deficiency II encodes a putative GDP-fucose transporter. Nat Genet 2001; 28:69-72.
31. Lubke T, Marquardt T, Etzioni A., Hartmann E, von Figura K, Korner C. Complementation cloning identifies CDG-IIc, a new type of congenital disorders of glycosylation, as a GDP-fucose transporter deficiency. Nat Genet 2001; 28:73-6.
32. Moriwaki K, Noda K, Nakagawa T., Asahi M, Yoshihara H, Taniguchi N., et al. A high expression of GDP-fucose transporter in hepatocellular carcinoma is a key factor for increases in fucosylation. Glycobiology 2007; 17:1311-20.
33. Lu L, Hou X, Shi S., Korner C, Stanley P. Slc35c2 promotes Notch1 fucosylation and is required for optimal Notch signaling in mammalian cells. J Biol Chem 2010; 285:36245-54.
34. Chen W, Tang J, Stanley P. Suppressors of alpha(1, 3)fucosylation identified by expression cloning in the LEC11B gain-of-function CHO mutant. Glycobiology 2005; 15:259-69.
35. Hiraoka S, Furuichi T, Nishimura G., Shibata S, Yanagishita M, Rimoin D.L., et al. Nucleotide-sugar transporter SLC35D1 is critical to chondroitin sulfate synthesis in cartilage and skeletal development in mouse and human. Nat Med 2007; 13:1363-7.
36. Chintala S, Tan J, Gautam R., Rusiniak ME, Guo X, Li W, et al. The Slc35d3 gene, encoding an orphan nucleotide sugar transporter, regulates platelet-dense granules. Blood 2007; 109:1533-40.
37. Wang TF, Guidotti G. Golgi localization and functional expression of human uridine diphosphatase. J Biol Chem 1998; 273:11392-9.
38. Martinez-Duncker I, Mollicone R, Codogno P., Oriol R. The nucleotide-sugar transporter family: a phylogenetic approach. Biochimie 2003; 85:245-60.
39. Deutscher SL, Nuwayhid N, Stanley P., Briles EI, Hirschberg CB. Translocation across Golgi vesicle membranes: a CHO glycosylation mutant deficient in CMP-sialic acid transport. Cell 1984; 39:295-9.
40. Abeijon C, Robbins PW, Hirschberg CB. Molecular cloning of the Golgi apparatus uridine diphosphate-N-acetylglucosamine transporter from Kluyveromyces lactis. Proc Natl Acad Sci U S A 1996; 93:5963-8.
41. Ishida N, Miura N, Yoshioka S., Kawakita M. Molecular cloning and characterization of a novel isoform of the human UDP-galactose transporter, and of related complementary DNAs belonging to the nucleotide-sugar transporter gene family. J Biochem 1996; 120:1074-8.
42. Miura N, Ishida N, Hoshino M., Yamauchi M, Hara T, Ayusawa D., et al. Human UDP-galactose translocator: molecular cloning of a complementary DNA that complements the genetic defect of a mutant cell line deficient in UDP-galactose translocator. J Biochem 1996; 120:236-41.
43. Gerardy-Schahn R, Oelmann S, Bakker H. Nucleotide sugar transporters: biological and functional aspects. Biochimie 2001; 83:775-82.
44. Hirschberg CB, Robbins PW, Abeijon C. Transporters of nucleotide sugars, ATP, and nucleotide sulfate in the endoplasmic reticulum and Golgi apparatus. Annu Rev Biochem 1998; 67:49-69.
45. Caffaro CE, Luhn K, Bakker H., Vestweber D, Samuelson J, Berninsone P., et al. A single Caenorhabditis elegans Golgi apparatus-type transporter of UDP-glucose, UDP-galactose, UDP-N-acetylglucosamine, and UDP-N-acetylgalactosamine. Biochemistry 2008; 47:4337-44.
46. Aoki K, Ishida N, Kawakita M. Substrate recognition by UDP-galactose and CMP-sialic acid transporters. Different sets of transmembrane helices are utilized for the specific recognition of UDP-galactose and CMP-sialic acid. J Biol Chem 2001; 276:21555-61.
47. Guillen E, Abeijon C, Hirschberg CB. Mammalian Golgi apparatus UDP-N-acetylglucosamine transporter: molecular cloning by phenotypic correction of a yeast mutant. Proc Natl Acad Sci U S A 1998; 95:7888-92.
48. Song Z. Roles of the nucleotide sugar transporters (SLC35 family) in health and disease. Mol Aspects Med 2013; 34:590-600.
49. Vastermark A, Almen MS, Simmen M.W., Fredriksson R., Schioth HB. Functional specialization in nucleotide sugar transporters occurred through differentiation of the gene cluster EamA (DUF6) before the radiation of Viridiplantae. BMC Evol Biol 2011; 11:123.
50. Handford M, Rodriguez-Furlán C, Orellana A. Nucleotide-sugar transporters: structure, function and roles in vivo. Braz J Med Biol Res 2006; 39:1149-58.
51. Ishida N, Yoshioka S, Iida M., Sudo K, Miura N, et al., Aoki K. Indispensability of transmembrane domains of Golgi UDP-galactose transporter as revealed by analysis of genetic defects in UDP-galactose transporter-deficient murine had-1 mutant cell lines and construction of deletion mutants. J Biochem 1999; 126:1107-17.
52. Eckhardt M, Gotza B, Gerardy-Schahn R. Membrane topology of the mammalian CMP-sialic acid transporter. J Biol Chem 1999; 274:8779-87.
53. Gao XD, Dean N. Distinct protein domains of the yeast Golgi GDP-mannose transporter mediate oligomer assembly and export from the endoplasmic reticulum. J Biol Chem 2000; 275:17718-27.
54. Engel J, Schmalhorst PS, Dork-Bousset T, Ferrieres V., Routier FH. A single UDP-galactofuranose transporter is required for galactofuranosylation in Aspergillus fumigatus. J Biol Chem 2009; 284:33859-68.
55. Hong K, Ma D, Beverley S.M., Turco SJ. The Leishmania GDP-mannose transporter is an autonomous, multi-specific, hexameric complex of LPG2 subunits. Biochemistry 2000; 39:2013-22.
56. Maszczak-Seneczko D, Sosicka P, Olczak T., Jakimowicz P, Majkowski M, Olczak M., et al. UDP-N-acetylglucosamine transporter (SLC35A3) regulates biosynthesis of highly branched N-glycans and keratan sulfate. J Biol Chem 2013; 288:21850-60.
57. Sprong H, Degroote S, Nilsson T., Kawakita M, Ishida N, van der Sluijs P. Association of the Golgi UDP-galactose transporter with UDP-galactose: ceramide galactosyltransferase allows UDP-galactose import in the endoplasmic reticulum. Mol Biol Cell 2003; 14:3482-93.
58. Duran AM, Meiler J. Inverted topologies in membrane proteins: a mini-review. Comput Struct Biotechnol J 2013; 8.
59. Ruggerone P, Vargiu AV, Collu F, Fischer N., Kandt C. Molecular dynamics computer simulations of multidrug RND efflux pumps. Comput Struct Biotechnol J 2013; 5.
60. Brandli AW, Hansson GC, Rodriguez-Boulan E, Simons K. A polarized epithelial cell mutant deficient in translocation of UDP-galactose into the Golgi complex. J Biol Chem 1988; 263:16283-90.
61. Toma L, Pinhal MA, Dietrich C.P., Nader HB, Hirschberg CB. Transport of UDP-galactose into the Golgi lumen regulates the biosynthesis of proteoglycans. J Biol Chem 1996; 271:3897-901.
62. Stanley P. Lectin-resistant CHO cells: selection of new mutant phenotypes. Somatic Cell Genet 1983; 9:593-608.
63. Oelmann S, Stanley P, Gerardy-Schahn R. Point mutations identified in Lec8 Chinese hamster ovary glycosylation mutants that inactivate both the UDP-galactose and CMP-sialic acid transporters. J Biol Chem 2001; 276:26291-300.
64. Sun-Wada GH, Yoshioka S, Ishida N., Kawakita M. Functional expression of the human UDP-galactose transporters in the yeast Saccharomyces cerevisiae. J Biochem 1998; 123:912-7.
65. Yoshioka S, Sun-Wada GH, Ishida N., Kawakita M. Expression of the human UDP-galactose transporter in the Golgi membranes of murine Had-1 cells that lack the endogenous transporter. J Biochem 1997; 122:691-5.
66. Kabuss R, Ashikov A, Oelmann S., Gerardy-Schahn R, Bakker H. Endoplasmic reticu-lum retention of the large splice variant of the UDP-galactose transporter is caused by a dilysine motif. Glycobiology 2005; 15:905-11.
67. Maszczak-Seneczko D, Olczak T, Wunderlich L., Olczak M. Comparative analysis of involvement of UGT1 and UGT2 splice variants of UDP-galactose transporter in glycosylation of macromolecules in MDCK and CHO cell lines. Glycoconj J 2011; 28:481-92.
68. Maszczak-Seneczko D, Olczak T, Jakimowicz P., Olczak M. Overexpression of UDP-GlcNAc transporter partially corrects galactosylation defect caused by UDP-Gal transporter mutation. FEBS Lett 2011; 585:3090-4.
69. Mo D, Costa SA, Ihrke G, Youker R.T., Pastor-Soler N, et al. Sialylation of N-linked gly-cans mediates apical delivery of endolyn in MDCK cells via a galectin-9-dependent mechanism. Mol Biol Cell 2012; 23:3636-46.
70. Takeshima-Futagami T, Sakaguchi M, Uehara E., Aoki K, Ishida N, Sanai Y., et al. Amino acid residues important for CMP-sialic acid recognition by the CMP-sialic acid transporter: analysis of the substrate specificity of UDP-galactose/CMP-sialic acid transporter chimeras. Glycobiology 2012; 22:1731-40.
71. Maszczak-Seneczko D, Sosicka P, Majkowski M., Olczak T, Olczak M. UDP-N-acetylglucosamine transporter and UDP-galactose transporter form heterologous complexes in the Golgi membrane. FEBS Lett 2012; 586:4082-7.
72. Olczak M, Maszczak-Seneczko D, Sosicka P., Jakimowicz P, Olczak T. UDP-Gal/UDP-GlcNAc chimeric transporter complements mutation defect in mammalian cells deficient in UDP-Gal transporter. Biochem Biophys Res Commun 2013; 434:473-8.
73. Fullekrug J, Sonnichsen B, Schafer U., Nguyen Van P, Soling HD, Mieskes G. Characterization of brefeldin A induced vesicular structures containing cycling proteins of the intermediate compartment/cis-Golgi network. FEBS Lett 1997; 404:75-81.
74. Hsu VW, Shah N, Klausner RD. A brefeldin A-like phenotype is induced by the overexpression of a human ERD-2-like protein, ELP-1. Cell 1992; 69:625-35.
75. Monier S, Chardin P, Robineau S., Goud B. Overexpression of the ARF1 exchange factor ARNO inhibits the early secretory pathway and causes the disassembly of the Golgi complex. J Cell Sci 1998; 111 (Pt 22):3427-36.
76. Lippincott-Schwartz J, Yuan LC, Bonifacino J.S., Klausner RD. Rapid redistribution of Golgi proteins into the ER in cells treated with brefeldin A: evidence for membrane cycling from Golgi to ER. Cell 1989; 56:801-13.
77. Misumi Y, Misumi Y, Miki K., Takatsuki A, Tamura G, Ikehara Y. Novel blockade by brefeldin A of intracellular transport of secretory proteins in cultured rat hepatocytes. J Biol Chem 1986; 261:11398-403.
78. Becker DJ, Lowe JB. Leukocyte adhesion deficiency type II. Biochim Biophys Acta 1999; 1455:193-204.
79. Zhang P, Haryadi R, Chan K.F., Teo G., Goh J, Pereira NA, et al. Identification of functional elements of the GDP-fucose transporter SLC35C1 using a novel Chinese hamster ovary mutant. Glycobiology 2012; 22:897-911.
80. Zhao W, Chen TLL, Vertel BM, Colley KJ. The CMP-sialic acid transporter is localized in the medial-trans Golgi and possesses two specific endoplasmic reticulum export motifs in its carboxyl-terminal cytoplasmic tail. J Biol Chem 2006; 281:31106-18.
81. Ma D, Russell DG, Beverley S.M., Turco SJ. Golgi GDP-mannose uptake requires Leishmania LPG2. A member of a eukaryotic family of putative nucleotide-sugar transporters. J Biol Chem 1997; 272:3799-805.
82. Dean N, Zhang YB, Poster JB. The VRG4 geneisrequired for GDP-mannose transport into the lumen of the Golgi in the yeast, Saccharomyces cerevisiae. J Biol Chem 1997; 272:31908-14.
83. Suda T, Kamiyama S, Suzuki M., Kikuchi N, Nakayama K, Narimatsu H., et al. Molecular cloning and characterization of a human multisubstrate specific nucleotide-sugar transporter homologous to Drosophila fringe connection. J Biol Chem 2004; 279:26469-74.
84. Ishida N, Kuba T, Aoki K., Miyatake S, Kawakita M, Sanai Y. Identification and characterization of human Golgi nucleotide sugar transporter SLC35D2, a novel member of the SLC35 nucleotide sugar transporter family. Genomics 2005; 85:106-16.
85. Muraoka M, Kawakita M, Ishida N. Molecular characterization of human UDP-glucuronic acid/UDP-N-acetylgalactosamine transporter, a novel nucleotide sugar transporter with dual substrate specificity. FEBS Lett 2001; 495:87-93.
86. Abeijon C, Orlean P, Robbins P.W., Hirschberg CB. Topography of glycosylation in yeast: characterization of GDPmannose transport and lumenal guanosine diphosphatase activities in Golgi-like vesicles. Proc Natl Acad Sci U S A 1989; 86:6935-9.
87. Bernard M, Latge JP. Aspergillus fumigatus cell wall: composition and biosynthesis. Med Mycol 2001; 39 (Suppl. 1):9-17.
88. Engel J, Schmalhorst PS, Routier FH. Biosynthesis of the fungal cell wall polysaccha-ride galactomannan requires intraluminal GDP-mannose. J Biol Chem 2012; 287:44418-24.
89. Gaur U, Showalter M, Hickerson S., Dalvi R, Turco SJ, Wilson ME. Leishmania donovani lacking the Golgi GDP-Man transporter LPG2 exhibit attenuated virulence in mammalian hosts. Exp Parasitol 2009; 122:182-91.
90. Mayer M, Meyer B. Characterization of ligand binding by saturation transfer difference NMR spectroscopy. Angew Chem Int Ed 1999; 38:1784-8.
91. Meyer B, Peters T. NMR spectroscopy techniques for screening and identifying li-gand binding to protein receptors. Angew Chem Int Ed Engl 2003; 42:864-90.
92. Maggioni A, von Itzstein M, Tiralongo J, Haselhorst T. Detection of ligand binding to nu-cleotide sugar transporters by STD NMR spectroscopy. Chembiochem 2008; 9:2784-6.
93. Maggioni A, Meier J, Routier F., Haselhorst T, Tiralongo J. Direct investigation of the Aspergillus GDP-mannose transporter by STD NMR spectroscopy. Chembiochem 2011; 12:2421-5.
94. Maggioni A, von Itzstein M, Rodriguez Guzman IB, Ashikov A, Stephens AS, Haselhorst T, et al. Characterisation of CMP-sialic acid transporter substrate recognition. Chembiochem 2013; 14:1936-42.
95. Tiralongo J, Haselhorst T. Sialic acid derivatives, analogues and mimetics as biological probes and inhibitors of sialic acid recognizing proteins. In: Grunwald P, editor. Carbohydrate Modifying Biocatalysts. Singapore: Pan Stanford Publishing; 2011. p. 478-503.
96. Eckhardt M, Muhlenhoff M, Bethe A., Gerardy-Schahn R. Expression cloning of the Golgi CMP-sialic acid transporter. Proc Natl Acad Sci U S A 1996; 93:7572-6.
97. Eckhardt M, Gerardy-Schahn R. Molecular cloning of the hamster CMP-sialic acid transporter. Eur J Biochem 1997; 248:187-92.
98. Eckhardt M, Gotza B, Gerardy-Schahn R. Mutants of the CMP-sialic acid transporter causing the Lec2 phenotype. J Biol Chem 1998; 273:20189-95.
99. Lim SF, Lee MM, Zhang P, Song Z. The Golgi CMP-sialic acid transporter: a new CHO mutant provides functional insights. Glycobiology 2008; 18:851-60.
100. Aoki K, Ishida N, Kawakita M. Substrate recognition by nucleotide sugar transporters: further characterization of substrate recognition regions by analyses of UDP-galactose/CMP-sialic acid transporter chimeras and biochemical analysis of the substrate specificity of parental and chimeric transporters. J Biol Chem 2003; 278:22887-93.
101. Chan KF, Zhang P, Song Z. Identification of essential amino acid residues in the hydrophilic loop regions of the CMP-sialic acid transporter and UDP-galactose transporter. Glycobiology 2010; 20:689-701.
102. Ferre F, Clote P. DiANNA 1.1: an extension of the DiANNA web server for ternary cysteine classification. Nucleic Acids Res 2006; 34:W182-5.
103. Datta AK, Chammas R, Paulson JC. Conserved cysteines in the sialyltransferase sialylmotifs form an essential disulfide bond. J Biol Chem 2001; 276:15200-7.